SIAP
ALDX icon

Sterling Investment Advisors (Pennsylvania)’s Aldeyra Therapeutics ALDX Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-345
Closed -$4K – 567
2021
Q2 		$4K Hold
345
– – ﹤0.01% 469
2021
Q1 		$4K Hold
345
– – ﹤0.01% 459
2020
Q4 		$2K Hold
345
– – ﹤0.01% 423
2020
Q3 		$3K Hold
345
– – ﹤0.01% 399
2020
Q2 		$1K Hold
345
– – ﹤0.01% 405
2020
Q1 		$0 Buy
+345
New +$1.55K ﹤0.01% 391

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Sterling Investment Advisors (Pennsylvania)'s ALDX Position: Q3 2021 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Aldeyra Therapeutics (ALDX) in Q3 2021, closing a stake of 345 shares — an estimated $4K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in ALDX in Q1 2020 and held it in 6 quarters. The position peaked at $4K in Q2 2021. 117 funds tracked by Wall St. Rank hold ALDX as of Q3 2021.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Aldeyra Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 345 Aldeyra Therapeutics shares in Q3 2021, an estimated $4K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Aldeyra Therapeutics in Q1 2020 and held it in 6 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Aldeyra Therapeutics position peaked at $4K in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2021.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2021, filed 9 Nov 2021.